The Staphylococcus aureus secretome - TI Pharma
The Staphylococcus aureus secretome - TI Pharma
The Staphylococcus aureus secretome - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 7<br />
Materials and Methods<br />
Bacterial strains, plasmids and growth media<br />
<strong>The</strong> bacterial strains and plasmids used in this study are listed in Table 1.<br />
Table 1. Strains and plasmids used in this study<br />
Plasmids Relevant properties Reference<br />
pDG783 pSB118 derivative; contains the kanamycin resistance marker<br />
from Streptococcus faecalis; Amp R ; Km R<br />
(Guérout-Fleury et<br />
al., 1995)<br />
pUC18 Ap R , ColE1, φ80lacZ, lac promoter (Sambrook et al.,<br />
1989)<br />
pX Vector for the integration of genes in the amyE locus of B.<br />
subtilis; integrated genes will be transcribed from the xylose<br />
inducible xylA promoter; carries the xylR gene; Amp R ; Cm R<br />
(Kim et al., 1996)<br />
pXTC pX derivative in which the chloramphenicol resistance marker<br />
has been replaced with a tetracycline resistance marker; Amp R (Darmon et al.,<br />
; 2006)<br />
Tet R<br />
TOPO pCR®-Blunt II-TOPO® vector; Km R Invitrogen Life<br />
Technologies, Inc.<br />
pMAD shuttle vector for E. coli and S. <strong>aureus</strong> with thermosensitive ori<br />
in S. <strong>aureus</strong>; contains the bgaB gene; Em R ; Amp R<br />
(Arnaud et al., 2004)<br />
pMAD-mscL pMAD plasmid with the flanking regions of S. <strong>aureus</strong> mscL;<br />
Em R ; Amp R<br />
This work<br />
BaSysBio II Ligation-independent cloning vector based on pDG1727 for<br />
Promoter-GFP activity analysis; Amp R , Spec R<br />
Stéphane Aymerich<br />
et al., unpublished<br />
Strains<br />
E. coli<br />
Genotype Reference<br />
DH5α F - , Ф80dlacZ ∆M15 endA1 recA1 gyrA96 thi-1 hsdR17 (rk- Invitrogen Life<br />
mk+) supE44 relA1 deoR ∆(lacZYA-argF) U169<br />
Technologies, Inc.<br />
TOP10 Cloning host for TOPO vector; F - mcrA ∆(mrr-hsdRMS-mcrBC)<br />
Φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU<br />
galK rpsL (Str R Invitrogen Life<br />
B. subtilis<br />
) endA1 nupG<br />
Technologies, Inc.<br />
168 trpC2 (Kunst et al., 1997)<br />
168 Cm trpC2; amyE::pX; Cm R<br />
(Dubois et al., 2009)<br />
∆SPβ trpC2; ∆SPβ; sublancin 168 sensitive (Dorenbos et al.,<br />
2002)<br />
∆SPβ Tc trpC2; ∆SPβ; amyE::pXTC; sublancin 168 sensitive; Tet R<br />
(Dubois et al., 2009)<br />
∆mscL trpC2; pMU<strong>TI</strong>N4mcs::mscL; double crossover deletion of mscL;<br />
Em R<br />
BSFA collection<br />
strain BFS1257<br />
∆SPβ∆mscL trpC2; ∆SPβ; pMU<strong>TI</strong>N4mcs::mscL; Em R This work<br />
Strains<br />
B. subtilis<br />
Genotype Reference<br />
∆sunA-<br />
∆yolF<br />
trpC2; ∆yolF; ∆sunA; Km R (Dubois et al., 2009)<br />
∆sunA trpC2; ∆sunA; Km R S. <strong>aureus</strong><br />
(Dubois et al., 2009)<br />
RN4220 Restriction-deficient derivative of NCTC 8325, cured of all (Kreiswirth et al.,<br />
known prophages; rsbU-; agr-<br />
1983)<br />
RN4220 RN4220 that contains the pMAD vector for erythromycin<br />
Em resistance; Em R<br />
This work<br />
RN4220<br />
∆mscL<br />
RN4220 derivative; rsbU-; agr-; ∆mscL This work<br />
134